What's breaking now, across thousands of outlets.
(MedPage Today) -- Results from a substudy of the phase III PROTEUS trial presented at the European Society for Medical Oncology (ESMO) congress showed that adding apalutamide (Erleada) and androgen-deprivation therapy (ADT) before and after radical...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Open enrollment can bring unexpected challenges for seniors.
Open enrollment can bring unexpected challenges for seniors.
Twenty-six years ago, the U.S. declared measles eliminated. That achievement is now at risk.
Researchers at Arizona State University, U.S., have found that a high-fat diet leaves lasting changes in intestinal stem cells, potentially increasing the risk of tumor development.
With a standardized cell naming system and infrastructure for data collection and analysis, the basal ganglia project sets the stage for a whole-brain primate atlas.
